Catalym is a Biotech company based in Martinsried, Germany. It has raised $319M in total funding. Latest round: Series D.
Catalym funding overview
Catalym is a Biotech company based in Martinsried, Germany. Catalym has raised $319M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in July 2024. The round record for Catalym runs through 2024; nothing later has been disclosed. Investors on record include Canaan Partners, Forbion Growth, Omega Funds, Jeito Capital, Novartis Venture Fund, Vesalius. 6 distinct backers are named across the disclosed rounds.
Catalym has raised $319M in total disclosed funding across the rounds on record.
Who has invested in Catalym?
Canaan Partners, Forbion Growth, Omega Funds, Jeito Capital, Novartis Venture Fund, Vesalius are named among the investors backing Catalym.
What was the latest Catalym funding round?
The most recent disclosed round is a Series D, announced in July 2024.
Where is Catalym based?
Catalym is based in Martinsried, Germany.
What sector does Catalym operate in?
Catalym is tracked under Biotech from Martinsried, Germany, with $319M in disclosed funding.
When did Catalym last raise?
The last disclosed Catalym round closed in July 2024 at Series D.
Catalym totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Martinsried below to benchmark round size and investor mix.
